logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
A

Andrew J. Krentz

king's college london

33H-index
241Paper Count
5.4KCitation Count
Published Papers 52
Publication Date
logo
Beyond Cardiovascular-Kidney-Metabolic Syndrome: Towards a Comprehensive Nexus of Cardiometabolic Multiple Long-term Conditions
errEuropean Journal of Preventive Cardiology
IF7.5
err2026-09-09
err0
PREAI
errAndrew J Krentz, MD, PhD; Stephan Jacob, MD; Peter Libby, MD, PhD; Robert H Eckel, MD
errShare
errSave
CVOT Summit Report 2025: advances along the cardiovascular–kidney–metabolic disease continuum
errCardiovascular Diabetology
IF10.6
err2026-05-06
err0
errOAAI
errOliver Schnell; Arnav Agarwal; Michel Azizi; Dennis Ballwieser; Katharine Barnard-Kelly; Tadej Battelino; Dennis Ballwieser; Matthias Blüher; Elisabetta Bugianesi; Ana Cebrian; Antonio Ceriello; Pratik Choudhary; Thomas Danne; Colin M. Dayan; Stefano Del Prato; Robert H. Eckel; Paola Fioretto; Timothy Garvey; Jennifer B. Green; Hiddo J. L. Heerspink; Rury R. Holman; Baruch Itzhak; Stephan Jacob; Pardeep S. Jhund; Linong Ji; Parminder K. Judge; Kamlesh Khunti; Marko Korenjak; Andrew J. Krentz; Ekaterini Lambrinou; Peter Libby; Julia K. Mader; Johannes F. E. Mann; Nikolaus Marx; Chantal Mathieu; John J. V. McMurray; Dirk Müller-Wieland; Nikolaos Papanas; Dipesh C. Patel; Andreas F. H. Pfeiffer; Susanne Reger-Tan; Helena W. Rodbard; Giuseppe M. C. Rosano; Banshi Saboo; Naoki Sato; Scott D. Solomon; Eberhard Standl; Frank Tacke; Pinar Topsever; Christoph Wanner; Sean Wharton; Veronika Young
errShare
errSave
Benchmarking survival machine learning models for 10-year cardiovascular disease risk prediction using large-scale electronic health records
errDIGITAL HEALTH
IF3.3
err2026-01-22
err0
PREAI
errTianyi Liu; Andrew Krentz; Lei Lu; Yanzhong Wang; Vasa Curcin
errShare
errSave
Improved cardiovascular outcomes with glucagon-like peptide-1 receptor agonists - what is the role of weight reduction?
errCARDIOVASCULAR ENDOCRINOLOGY & METABOLISM
IF1.1
err2025-12-01
err0
PREAI
errJacob, Stephan; Eckel, Robert H.; Krentz, Andrew J.
errShare
errSave
Global cardiometabolic alliance: A clinical and research initiative addressing the 21st century pandemic of insulin resistance-associated disease
errdiabetes obesity metabolism
IF0
err2025-08-14
err0
PREAI
errRobert H. Eckel MD; Andrew J. Krentz MB; Stephan Jacob MD; Peter Libby MD
errShare
errSave
Optimising the therapeutic response of statins using real-world evidence and machine learning: Personalised precision dosing recommends lower statin doses for some patients
errDIABETES OBESITY & METABOLISM
IF5.7
err2024-11-08
err0
PREAI
errKrentz, Andrew; Fournier, Lisa; Castiglione, Thomas; Curcin, Vasa; Hamdane, Camil; Liu, Tianyi; Jaun, Andre
errShare
errSave
Rising to the challenge of cardio-renal-metabolic disease in the 21st century: Translating evidence into best clinical practice to prevent and manage atherosclerosis (vol 396, 118528, 2024)
errATHEROSCLEROSIS
IF5.7
err2024-11-01
err0
errOAAI
errKrentz, Andrew; Jacob, Stephan; Heiss, Christian; Sattar, Naveed; Lim, Soo; Khunti, Kamlesh; Eckel, Robert H.
errShare
errSave
Comorbidity neural network model for personalised recommendations in cardiometabolic risk factor management: towards early precision medicine in routine clinical practice
errEUROPEAN HEART JOURNAL
IF35.6
err2024-10-28
err0
PREAI
errDibner, Y.; Brandt, N.; Curcin, V; Krentz, A.; Lozhkina, A.; Luster, A.; Pere, A.; Jaun, A.
errShare
errSave
Machine learning based prediction models for cardiovascular disease risk using electronic health records data: systematic review and meta-analysis
errEUROPEAN HEART JOURNAL - DIGITAL HEALTH
IF4.4
err2024-10-27
err2
errOAAI
errLiu, Tianyi; Krentz, Andrew; Lu, Lei; Curcin, Vasa
errShare
errSave
Rising to the challenge of cardio-renal-metabolic disease in the 21st century: Translating evidence into best clinical practice to prevent and manage atherosclerosis
errATHEROSCLEROSIS
IF5.7
err2024-09-01
err3
PREAI
errKrentz, Andrew; Jacob, Stephan; Heiss, Christian; Sattar, Naveed; Lim, Soo; Khunti, Kamlesh; Eckel, Robert H.
errShare
errSave
Therapy Recommendation Neural Network for Comorbid Cardiometabolic Diseases
errDIABETES
IF7.5
err2024-06-14
err0
PREAI
errDibner, Yaron; Brandt, Nicolas; Krentz, Andrew; Lozhkina, Arina; Luster, Alexandre; Pere, Arthur; Jaun, Andre
errShare
errSave
A Neural Network Model for the Prediction of Comorbid Cardiometabolic Diseases-Proof of Concept Using UK Primary Care Data
errDIABETES
IF7.5
err2023-06-20
err0
PREAI
errKrentz, Andrew; Brunschwig, Lucas S.; Dibner, Yaron; Michel, Hugo; Jaun, Andre
errShare
errSave
Evolution of Type 2 Diabetes Management from a Glucocentric Approach to Cardio-Renal Risk Reduction: The New Paradigm of Care
errDRUGS
IF14.4
err2021-07-24
err12
PREAI
errJacob, Stephan; Krentz, Andrew J.; Deanfield, John; Ryden, Lars
errShare
errSave
Managing hyperlipidaemia in patients with COVID-19 and during its pandemic: An expert panel position statement from HEART UK
errATHEROSCLEROSIS
IF5.7
err2020-11-01
err41
errOAAI
errIqbal, Zohaib; Ho, Jan Hoong; Adam, Safwaan; France, Michael; Syed, Akheel; Neely, Dermot; Rees, Alan; Khatib, Rani; Cegla, Jaimini; Byrne, Christopher; Qureshi, Nadeem; Capps, Nigel; Ferns, Gordon; Payne, Jules; Schofield, Jonathan; Nicholson, Kirsty; Datta, Dev; Pottle, Alison; Halcox, Julian; Krentz, Andrew; Durrington, Paul; Soran, Handrean
errShare
errSave
Evolution of pharmacological obesity treatments: focus on adverse side-effect profiles
errDIABETES OBESITY & METABOLISM
IF5.7
err2016-04-26
err132
PREAI
errKrentz, A. J.; Fujioka, K.; Hompesch, M.
errShare
errSave
Anti-Obesity Pharmacotherapy: The Intercontinental Regulatory Divide
errDRUGS
IF14.4
err2015-05-12
err4
errOAAI
errKrentz, Andrew J.; Fujioka, Ken; Hompesch, Marcus
errShare
errSave
Effect of exogenously administered glucagon versus spontaneous endogenous counter-regulation on glycaemic recovery from insulin-induced hypoglycaemia in patients with type 2 diabetes treated with a novel glucokinase activator, AZD1656, and metformin
errDIABETES OBESITY & METABOLISM
IF5.7
err2014-07-03
err3
PREAI
errKrentz, A. J.; Morrow, L.; Petersson, M.; Norjavaara, E.; Hompesch, M.
errShare
errSave
Targeting Hyperglycaemia with Anti-Obesity Drugs: Time for a Paradigm Shift?
errDRUGS
IF14.4
err2013-10-05
err4
errOAAI
errKrentz, Andrew J.; Hompesch, Marcus
errShare
errSave
Insulin resistance: a risk marker for disease and disability in the older person
errDIABETIC MEDICINE
IF3.4
err2013-04-15
err51
PREAI
errKrentz, A. J.; Viljoen, A.; Sinclair, A.
errShare
errSave
Adipocytokine profiles in a putative novel postmenopausal polycystic ovary syndrome (PCOS) phenotype parallel those in premenopausal PCOS: the Rancho Bernardo Study
errMETABOLISM-CLINICAL AND EXPERIMENTAL
IF11.9
err2012-09-01
err7
PREAI
errKrentz, Andrew J.; von Muehlen, Denise; Barrett-Connor, Elizabeth
errShare
errSave

Research Directions

The data has not been retrieved yet.
Co-authors
Cooperation Journals
P
Peter Libby
H-index: 227 · Papers: 1.3K
N
Naveed Sattar
H-index: 204 · Papers: 2.2K
K
Kamlesh Khunti
H-index: 162 · Papers: 2.1K
E
Elizabeth Barrett‐Connor
H-index: 143 · Papers: 857
J
John Deanfield
H-index: 140 · Papers: 923
View more